摘要
目的观察131Ⅰ治疗巨大甲状腺肿合并Graves甲亢的临床疗效。方法选取我院自2013年10月~2014年10月期间收治的巨大甲状腺肿合并Graves甲亢患者40例,对患者进行131Ⅰ按照每克甲状腺组织2~6.3 MBq/g给药治疗,患者出院后4~8个月回访。结果经过131Ⅰ治疗后的4个月,22例(55%)的甲状腺功能恢复正常,11例(27.5%)的甲状腺功能亢进,7例(17.5%)的甲状腺功能减退,其中有33例(82.5%)的甲状腺肿大恢复正常,7例的甲状腺重量均有所下降。经过131Ⅰ治疗后的8个月,27例(67.5%)甲状腺功能恢复正常,8例(20%)甲状腺功能亢进,5例(12.5%)甲状腺功能减退,其中有37例(92.5%)的甲状腺肿大恢复正常,剩余3例的甲状腺重量均有所下降。结论临床上应用131Ⅰ治疗巨大甲状腺肿合并Graves甲亢取得的临床疗效显著。
Objective To observe the clinical efficacy of131I treatment of huge goiter merge graves hyperthyroidism.Methods 40 cases of large goiter hyperthyroidism patients with Graves in our hospital from 2013 October to 2014 October who were treated,according to 131I per gram of thyroid tissue from 2 to 6.3 MBq/g drug treatment,patients were discharged after 4~8 months visit.ResultsAfter 4 months and131I treatment,22 cases（55%） of the thyroid function was normal,11 cases（27.5%）of the hyperthyroidism,7 cases（17.5%）of hypothyroidism,33 cases（82.5%）of the thyroidenlargement returned to normal,7 cases of thyroid weight are decreased. After 8 months and131I treatment,27 cases（67.5%）of the thyroid function was normal,8 cases（20%）of the hyperthyroidism,5 cases（12.5%）of hypothyroidism,37 cases（92.5%）of the thyroid enlargement returned to normal,the remaining 3 cases thyroid weight decreased.Conclusion The clinical curative effect of clinical application of131I treatment of huge goiter merge graves hyperthyroidism has significant.
出处
《中国卫生标准管理》
2015年第8期252-253,共2页
China Health Standard Management
